Triple Analysis: Angiogenesis, Cancer Vaccines and Antibodies

BioSeeker Group AB
March 19, 2013
5072 Pages - SKU: BIOS5014693
Global & Usa Cancer Immunotherapy Market Analysis To 2020: Antibody Drug Conjugates (ADCs), Bispecific Monoclonal Antibodies, Cancer Vaccines, Cytokines, Interferons, Chimeric Antigen Receptor (CAR) T-Cell Therapy, PD-1/PD-L1 inhibitors, Dendritic Cells,
4/1/2015 | published by: Kelly Scientific Publications
Global & Usa Cancer Immunotherapy Market Analysis To 2020: Antibody Drug Conjugates (ADCs), Bispecific Monoclonal Antibodies, Cancer Vaccines, Cytokines, Interferons, Chimeric Antigen Receptor (CAR) T-Cell Therapy, PD-1/PD-L1 inhibitors, Dendritic Cells, Checkpoint Inhibitors, Adopted Cell Therapy  |  read more...
USD 3,400
Engineered TCR and CAR Immunotherapeutics 2015
3/11/2015 | published by: La Merie Publishing
Engineered TCR and CAR Immunotherapeutics 2015 The engineered T cell receptor (TCR) for targeting of intracellur targets not druggable by conventional antibody technologies, and specifically targeted  |  read more...
USD 2,630
Antibody Deals and Alliances of 2014
3/1/2015 | published by: Current Partnering
Antibody Deals and Alliances of 2014 The Antibody Deals and Alliances of 2014 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies during 2014.  |  read more...
USD 1,495
Antibody Drug Conjugate Insight: Pipeline Assessment, Technology Trend, and Competitive Landscape, 2015
3/1/2015 | published by: DelveInsight
Antibody Drug Conjugate Insight: Pipeline Assessment, Technology Trend, and Competitive Landscape, 2015 Summary: DelveInsight’s Antibody-Drug Conjugate: Global Market and Pipeline Outlook, 2015, report provides the information across the ADCs drug value chain. The  |  read more...
USD 3,500
Global MABS Industry 2014 Market Research Report
1/10/2015 | published by: 9Dimen Research
2014 Global MABS Industry Report is a professional and in-depth research report on the world's major regional market conditions of the MABS industry, focusing on the main regions (North America, Europe and Asia) and the  |  read more...
USD 2,850
Cancer Vaccines: Technologies and Global Markets
1/1/2015 | published by: BCC Research
Cancer Vaccines: Technologies and Global Markets REPORT HIGHLIGHTS The global market for cancer vaccines was about $4.5 billion in 2013. This market reached about $4.0 billion in 2014 and is expected to reach  |  read more...
USD 6,650
Vaccine Market by Technology (Live Attenuated, Toxoid, Conjugate, Subunit, Synthetic, Dendritic Cell, Inactivated), Type (Preventive, Therapeutic), End User (Pediatrics, Adults), Disease Indication (Infectious Disease, Cancer, Allergy) - Forecasts to 2019
1/26/2015 | published by: MarketsandMarkets
Vaccine Market by Technology (Live Attenuated, Toxoid, Conjugate, Subunit, Synthetic, Dendritic Cell, Inactivated), Type (Preventive, Therapeutic), End User (Pediatrics, Adults), Disease Indication (Infectious Disease, Cancer, Allergy) - Forecasts to 2019 The vaccines market is  |  read more...
USD 4,650
Global Markets for Research Antibodies
1/1/2015 | published by: BCC Research
Global Markets for Research Antibodies The global market for research antibodies reached $2 billion in 2013 and nearly $2.2 billion in 2014. This market is expected to reach nearly $3 billion in 2019, registering  |  read more...
USD 6,650
Antibodies in Oncology: Drug Pathway Analyzer 2015
1/12/2015 | published by: BioSeeker Group AB
Extra value: One year of free online updates included with this product There are today at least 701 antibody drugs known to affect more than 213 specific intracellular signaling pathways for the treatment of more than  |  read more...
USD 6,746
Antibodies in Oncology Drug Pipeline Update 2015
1/5/2015 | published by: BioSeeker Group AB
The commercial and therapeutic success of antibodies like Rituxan, Avastin, and Erbitux will force the industry to look into the next generation of therapeutic antibodies, preparing themselves for the second wave in the lucrative field  |  read more...
USD 6,746
 

SELECT A LICENSE

    PDF E-mail From Publisher  USD 5,175  
    Global Site License Fulfilled by Publisher  USD 12,937.50  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!